Phase 1/2 Study of PYX-201 in Combination with Pembrolizumab in Advanced Solid Tumors

Status

Not yet recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-521828-30-00

Acronym

PYX-201-102

Enrollment

Registered

2025-11-19

Start date

Unknown

Completion date

Unknown

Last updated

2025-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Solid Tumors

None listed

Sex/Gender

All

Age

18 Years to No maximum

France, Poland, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026